[
  {
    "title": "Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment",
    "published": 1742288480,
    "posting_price": 9.25,
    "close_price": 9.52000046,
    "percent_change": 2.91892389
  },
  {
    "title": "Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks",
    "published": 1741856473,
    "posting_price": 9.27000046,
    "close_price": 8.97999954,
    "percent_change": -3.12838086
  },
  {
    "title": "1 Healthcare Stock to Target This Week and 2 to Turn Down",
    "published": 1741698119,
    "posting_price": 9.48999977,
    "close_price": 9.34000015,
    "percent_change": -1.5806072
  },
  {
    "title": "Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers",
    "published": 1741165429,
    "posting_price": 9.23373042,
    "close_price": 9.362113,
    "percent_change": 1.39036526
  },
  {
    "title": "Viatris Q4 Earnings and Revenues Miss Estimates, Stock Plunges",
    "published": 1740682560,
    "posting_price": 9.14484941,
    "close_price": 9.41149139,
    "percent_change": 2.9157613
  },
  {
    "title": "Viatris Appoints Corinne Le Goff as Chief Commercial Officer",
    "published": 1713182400,
    "posting_price": 10.94880495,
    "close_price": 10.84343529,
    "percent_change": -0.96238503
  },
  {
    "title": "Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone\u00ae 20 mg/mL Once-Daily in Canada",
    "published": 1713178740,
    "posting_price": 10.94880495,
    "close_price": 10.84343529,
    "percent_change": -0.96238503
  },
  {
    "title": "Viatris names Corinne Le Goff as Chief Commercial Officer",
    "published": 1713164700,
    "posting_price": 10.94880495,
    "close_price": 10.84343529,
    "percent_change": -0.96238503
  },
  {
    "title": "Viatris Enters Oversold Territory",
    "published": 1712918220,
    "posting_price": 11.06375336,
    "close_price": 10.85301495,
    "percent_change": -1.90476417
  },
  {
    "title": "Viatris Stock: Way Too Undervalued With $1 Billion Buyback Potential",
    "published": 1712595676,
    "posting_price": 11.2744914,
    "close_price": 11.25533295,
    "percent_change": -0.1699274
  },
  {
    "title": "UK's Theramex sees no impact to HRT products supply after CMA probe",
    "published": 1712324356,
    "posting_price": 11.2265964,
    "close_price": 11.30322838,
    "percent_change": 0.68259317
  },
  {
    "title": "Competition watchdog says HRT drug deal could raise prices",
    "published": 1712231452,
    "posting_price": 11.64807351,
    "close_price": 11.26491356,
    "percent_change": -3.28947057
  },
  {
    "title": "UPDATE 1-UK watchdog says Theramex-Viatris deal raises competition concerns",
    "published": 1712227948,
    "posting_price": 11.64807351,
    "close_price": 11.26491356,
    "percent_change": -3.28947057
  },
  {
    "title": "Pharma deal could reduce choice and lead to higher prices for HRT treatments",
    "published": 1712220251,
    "posting_price": 11.64807351,
    "close_price": 11.26491356,
    "percent_change": -3.28947057
  },
  {
    "title": "UK watchdog says Theramex-Viatris deal raises competition concerns",
    "published": 1712211983,
    "posting_price": 11.64807351,
    "close_price": 11.26491356,
    "percent_change": -3.28947057
  },
  {
    "title": "Is Viatris Inc (VTRS) Set to Underperform? Analyzing the Factors Limiting Growth",
    "published": 1712138640,
    "posting_price": 11.38943842,
    "close_price": 11.51396561,
    "percent_change": 1.09335672
  },
  {
    "title": "Viatris Announces the Launch of RYZUMVl 0.75% in the United States",
    "published": 1712049641,
    "posting_price": 11.36070208,
    "close_price": 11.43733406,
    "percent_change": 0.6745356
  },
  {
    "title": "Zacks Industry Outlook Highlights Teva, Dr. Reddy's and Viatris",
    "published": 1713520800,
    "posting_price": 10.68059201,
    "close_price": 10.77638245,
    "percent_change": 0.89686452
  },
  {
    "title": "3 Generic Drug Stocks to Watch Amid Challenging Market Prospects",
    "published": 1713453120,
    "posting_price": 10.65185547,
    "close_price": 10.65185547,
    "percent_change": 0.0
  },
  {
    "title": "Bill Miller\u2019s Latest 13 Stock Picks",
    "published": 1713448483,
    "posting_price": 10.65185547,
    "close_price": 10.65185547,
    "percent_change": 0.0
  },
  {
    "title": "Viatris to Report First Quarter 2024 Financial Results on May 9, 2024",
    "published": 1713299400,
    "posting_price": 10.78596189,
    "close_price": 10.65185547,
    "percent_change": -1.24334224
  }
]